Viewing nowLipitor 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

MFDS item code 200410090 · Approved 2004.11.25 · Insurance code 073400340
Improves hyperlipidemia and prevents cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiac and vascular diseases. It lowers the risk of myocardial infarction and stroke in elderly patients and adult patients with various risk factors such as hypertension, smoking, and family history, and decreases the risk of vascular interventions or angina. It also reduces the risk of cardiovascular disease in diabetic patients. Furthermore, it has a proven effect in reducing the risk of non-fatal myocardial infarction, stroke, and hospitalization for congestive heart failure in patients who have direct clinical evidence. This medication is also used in patients with hyperlipidemia to lower cholesterol and triglyceride levels while increasing HDL cholesterol, improving the blood lipid profile. It can also benefit certain children and adolescents with hypercholesterolemia. Therefore, this medication is used in the treatment of cardiovascular diseases and dyslipidemia.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such lipid-lowering therapies are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in older patients aged 70 years or older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses greater than 20 mg of this medication in pediatric patients). Adjust the dose as appropriate for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle problems; therefore, if symptoms such as muscle pain or weakness occur, you should stop taking it immediately and consult your doctor. This medication can affect liver function, so it should not be used in patients with liver disease or abnormal liver function test results. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It is not administered to children, especially those under 10 years of age. Patients with a history of alcohol abuse or liver disease should be particularly cautious when using this medication. Patients over 70 years of age are at a higher risk of developing myopathy; thus, muscle-related symptoms should be carefully monitored during use. The risk of side effects may increase when this medication is taken with certain drugs; patients taking other medications should inform their doctor or pharmacist. Special caution is required when taken with certain antibiotics, antifungals, HIV medications, hepatitis treatments, and grapefruit juice. This medication contains lactose; therefore, patients with lactose intolerance should confirm before taking it. It is important to regularly monitor liver function tests and blood tests for abnormalities during treatment. If symptoms such as muscle pain, weakness, or fever occur, immediate notification to medical personnel is necessary, and if severe, treatment should be discontinued. Appropriate contraceptive methods should be used during the course of taking this medication, and if pregnancy is confirmed, treatment should be discontinued immediately. There is no specific antidote for overdose, so treatment should be symptomatic, monitoring liver function and muscle damage carefully. Keep out of reach of children and store in the original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is also recommended to store it at room temperature, avoiding extremes of heat or cold.
White round film-coated tablet
28 tablets (7 tablets/blister x 4), 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.